Biomanufacturing will be the defining industrial capability of the exploration and commercialization of space. Without the natural processes of Earth, biomanufacturing will be critical to make the air we breathe, the food we eat, every chemical or plastic we produce, and much more. 

Today, this same technology solves an immediate need – making the in-space production of biologic pharmaceuticals. In space, you can make better biologics (drugs made of large proteins). The microgravity of space makes it possible to form these drugs into purer, more uniform crystals that make these drugs more injectable and stable, both key challenges in the biopharma industry. 

While Crystallization is the unique advantage of space, it is not the primary hurdle to make these drugs come to market. Scale is.

Ambrosia is solving this problem. Building the whole biologic manufacturing process in space. This begins with bringing the largest, most capable, biomanufacturing system flown to space. From there Ambrosia will expand its technology to include the downstream processing and purification systems necessary to repeatably and efficiently produce a variety of valuable products in space.

Biopharma is where this industry starts. Ambrosia’s core biomanufacturing technologies will form the backbone of life off-Earth. 

Ambrosia Space is building the off-Earth industrial company.